EUROpean Treatment & Reduction of Acute Coronary Syndrome cost analysis (EUROTRACS)
Executive Agency for Health and Consumers
PSMAR • HCC • DEASL • FMUP • HMGU • ESREFO • AEPMCV • ISS
The present proposal’s main objective consists of utility analysis (cost-effectiveness) in terms of cost per Quality-Adjusted Life Year (QALY) saved in two fields:
1) three population interventions (and their combinations) designed to prevent coronary artery disease incidence aimed at reducing smoking, dyslipidaemia, and hypertension population prevalence, and
2) optimal use of coronary angiography and percutaneous intervention procedures in the management of patients with acute coronary syndrome (ACS) with special emphasis on the elderly (>64 years) to minimize the inequalities in this patient subgroup that has higher mortality than patients.